Small Molecule Drug Discovery Market Size, Share, Opportunities, And Trends By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, Others), By Phase/Process (Target Discovery, Target Validation, Lead Generation and Refinement, Preclinical Development), By End-User (Pharmaceutical Companies, Contract Research Organizations), And By Geography - Forecasts From 2024 To 2029

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. SMALL MOLECULE DRUG DISCOVERY MARKET BY THERAPEUTIC AREA

5.1. Introduction

5.2. Oncology

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.3. Central Nervous System

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.4. Cardiovascular

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.5. Respiratory

5.5.1. Market Trends and Opportunities

5.5.2. Growth Prospects

5.6. Orthopedics

5.6.1. Market Trends and Opportunities

5.6.2. Growth Prospects

5.7. Immunology

5.7.1. Market Trends and Opportunities

5.7.2. Growth Prospects

5.8. Rare Diseases

5.8.1. Market Trends and Opportunities

5.8.2. Growth Prospects

5.9. Others

5.9.1. Market Trends and Opportunities

5.9.2. Growth Prospects

6. SMALL MOLECULE DRUG DISCOVERY MARKET BY PROCESS/ PHASE 

6.1. Introduction

6.2. Target Discovery

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Target Validation

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Lead Generation and Refinement

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.5. Preclinical Development

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

7. SMALL MOLECULE DRUG DISCOVERY MARKET BY END-USER

7.1. Introduction

7.2. Pharmaceutical Companies

8.2.1. Market Trends and Opportunities

8.2.2. Growth Prospects

7.3. Contract Research Organizations

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

8. SMALL MOLECULE DRUG DISCOVERY MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Therapeutic Area

8.2.2. By Process/ Phase 

8.2.3. By End User

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Therapeutic Area

8.3.2. By Process/ Phase 

8.3.3. By End User

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Therapeutic Area

8.4.2. By Process/ Phase 

8.4.3. By End User

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Trends and Opportunities

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Therapeutic Area

8.5.2. By Process/ Phase 

8.5.3. By End User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Therapeutic Area

8.6.2. By Process/ Phase 

8.6.3. By End User

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Taiwan

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Trends and Opportunities

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Trends and Opportunities

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Laboratory Corporation of America Holdings

10.2. Eurofins Scientific SE

10.3. Charles River Laboratories International, Inc.

10.4. Evotec SE

10.5. Wuxi AppTec

10.6. Syngene International Limited

10.7. Curia Global Inc.

10.8. Pharmaron Beijing Co., Ltd.

10.9. Thermo Fisher Scientific Inc. 

10.10. Jubilant Pharmova Limited